Page last updated: 2024-09-04

hyoscyamine and flunisolide

hyoscyamine has been researched along with flunisolide in 1 studies

Compound Research Comparison

Studies
(hyoscyamine)
Trials
(hyoscyamine)
Recent Studies (post-2010)
(hyoscyamine)
Studies
(flunisolide)
Trials
(flunisolide)
Recent Studies (post-2010) (flunisolide)
9915528612532

Protein Interaction Comparison

ProteinTaxonomyhyoscyamine (IC50)flunisolide (IC50)
Glucocorticoid receptorHomo sapiens (human)0.0053
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)0.0053
Glycine receptor subunit betaRattus norvegicus (Norway rat)0.0053
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)0.0053
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)0.0053

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1

Other Studies

1 other study(ies) available for hyoscyamine and flunisolide

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012